Medusa Medical Technologies Inc.'s flagship electronic patient care reporting software, Siren ePCR Suite, now has an interface with the Philips HeartStart MRx monitor/defibrillator. This integrated solution is available worldwide and enables an easier workflow for patient care and reporting in the pre-hospital setting.

Siren ePCR Suite is an industry-leading patient care reporting system. It enables paramedics to administer care while recording critical patient data that they transmit in real-time to receiving facilities. Siren ultimately improves data accuracy by downloading data from the HeartStart MRx directly into the tablet PC software, including ECG, vitals, treatments, and events. This system helps to support a decrease of discovery-to-treatment times by enabling the patient’s care to be evaluated and treatment to be given en route to the hospital.

"Good quality patient care requires good information," says Medusa vice president of product management, Craig Fraser. "Siren integrates with other systems to help provide all healthcare professionals with a holistic view of the patient’s care."

The Philips HeartStart MRx monitor/defibrillator combines diagnostic patient monitoring, defibrillation, and CPR measurement and feedback into a lightweight and intuitive package designed for use by ALS responders and hospital clinicians.  For electronic Patient Care Reporting (ePCR) software vendors, Philips offers the HeartStart Data Software Developer Kit (SDK), which allows data from Philips HeartStart monitor/defibrillators and AEDs to flow seamlessly into patient care reports.

"We are very pleased to add the Medusa Siren application to the open systems portfolio of solutions available with the Philips HeartStart MRx," said Michael Miller, senior vice president and general manager of cardiac care at Philips Healthcare. "Medusa is a leading international e-PCR provider, and EMS services will benefit from improved patient information flow in an open and interoperable environment."

Using this new solution, pre-hospital care providers in the field will be able to monitor the patient's current condition, as well as access a patient care database that helps them make more informed decisions and deliver better care to patients. The data from the HeartStart MRx, including patient vitals and waveforms, are recorded in the ePCR, ensuring continuity of care from the ambulance to and through the hospital.

With tremendous success in North America, the UK, and most recently in the Netherlands, Medusa continues to build strong relationships with a multitude of vendors throughout the world to help integrate Siren with other solutions. "Philips is a major player in the healthcare industry and we are very happy to add the MRx interface to our suite of available defibrillator interfaces," said Scott Campbell, Medusa president and CEO.  

About Medusa Medical Technologies Inc. (WWW.MEDUSAMEDICAL.COM)
Medusa revolutionized EMS patient care documentation in the late 1990s with the introduction of Siren ePCR Suite. Now used by thousands of paramedics worldwide, Medusa continues to drive ePCR technology to improve patient care with our award-winning, enterprise grade software. Today, we lead the industry with innovative solutions like hospital notification systems and real-time data communications.

About Siren ePCR
The Siren ePCR Suite is a secure electronic patient care reporting system that improves the speed and accuracy with which paramedics can record patient information. Designed for use on-scene or in ambulances en route to the hospital, the Siren ePCR™ software and complementary hardware employ an easy-to-use, touch-screen interface to provide paramedics with more efficient data capture tools.

With this system, patient data recording is quicker and more accurate than with traditional pencil and paper. Ultimately, the Siren ePCR Suite allows paramedics to spend less time documenting patients’ ailments – and more time treating them.

Siren ePCR and Siren ePCR Suite are trademarks of Medusa Medical Technologies Inc.

For more information, please contact:
Angie Hopper
Medusa Medical Technologies Inc.
T +1-902-429-1200 (ext 227)

Halifax, Nova Scotia, January 27, 2009